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The adenovirus IVa2 is an intermediate viral gene product that appears to perform multiple essential roles in viral infection. Using IVa2 as
bait in the yeast two-hybrid system, we screened selected open reading frames (ORFs) of porcine adenovirus (PAdV)-3 for potential
interaction with IVa2. Interestingly, pVIII showed specific interaction with IVa2. The yeast two-hybrid findings were validated by GST pull-
down assays, in vitro binding studies employing cell-free coupled transcription–translation products and in vitro co-immunoprecipitations
using protein-specific antibodies. Finally, we demonstrated that IVa2 specifically interacts with pVIII during PAdV-3 infection.
D 2005 Elsevier Inc. All rights reserved.
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Adenoviruses constitute a large group of DNA viruses
that infect a wide variety of hosts. The tight regulation of
gene expression in adenoviruses ensures four distinct phases
of gene activities: pre-early, early, intermediate, and late
stages, which leads to the production of infectious viral
particles. The E1a, E1b, E2, E3, E4, and L1 transcriptional
units are expressed before the onset of DNA replication.
Based on the kinetics of expression, two genes encoding
for pIX and IVa2 proteins are classified as intermediate
region genes (Edvardsson et al., 1976). IVa2 is a structural
component of the virion and appears to play a critical role in
the transition from the early to the late phase of the lytic
cycle of human adenovirus (HAdV)-5 (Lutz and Kedinger,
1996). It also acts as a transcriptional activator of the major
late promoter (MLP) of HAdV-5 (Mondesert et al., 1992;0042-6822/$ - see front matter D 2005 Elsevier Inc. All rights reserved.
doi:10.1016/j.virol.2005.03.003
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While IVa2 interacts specifically with the 52/55-kDa protein
during the course of HAdV-5 infection (Gustin et al., 1996),
this interaction does not appear to be involved in binding of
IVa2 protein to the downstream (DE) elements of MLP and
packaging sequence A repeats (Zhang and Imperiale, 2000).
Mutations in the conserved motifs of the A repeats eliminate
the binding of IVa2, indicating that the IVa2-52/55-kDa
interaction may play some role in the encapsidation of viral
DNA (Zhang and Imperiale, 2000). Recent studies have
suggested that the IVa2 protein is required for adenoviral
assembly and its function is serotype specific (Zhang and
Imperiale, 2003; Zhang et al., 2001).
We have been carrying out molecular characterization of
PAdV-3 with the aim of developing it as a vaccine delivery
vehicle for animals and humans (Reddy et al., 1999a,
1999b; Zakhartchouk et al., 2003). Although overall
organization of the PAdV-3 genome appears similar to other
Mastadenoviruses (Fraser and Ziff, 1978), recent studies
have begun to demonstrate differences between PAdV-3 and
other adenoviruses (Reddy et al., 1998). PAdV-3 IVa2 is
expressed as a spliced mRNA species lacking an intron of
257 nucleotides (Reddy et al., 1998). The PAdV-3 IVa2005) 60–69
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proteins of other adenoviruses (Reddy et al., 1998). The
conservation of IVa2 protein throughout the Mastadenovi-
ruses together with its well-known multiple functions in the
adenoviral life cycle suggests that IVa2 might be involved in
the interaction with other viral or cellular protein(s). Earlier
report indicated that IVa2 interacts with 52K in HAdV-5-
infected cells (Gustin et al., 1996). In this study, we
demonstrate that IVa2 and pVIII are also true partners
during the course of PAdV-3 infection.Results
Yeast two-hybrid assays
To characterize the role of IVa2 with respect to its
physical interaction(s) with other structural/regulatory pro-
teins during infection, we used the Matchmaker GAL4 two-
hybrid system 3 (BD Biosciences, Clontech). In this system,
two plasmid borne gene fusions are cotransformed into
yeast cells, and the interaction between these two fusion
proteins is measured by the reconstitution of a functional
transcriptional activator that triggers the expression of
reporter genes lacZ, HIS3, and ADE2. The IVa2 ORF
(Table 1) amplified by PCR (Table 2) was cloned in
pGBKT7 vector and used as a bait while ORFs representing
the selective late proteins (Table 1) encoded by L1 to L5
region were individually cloned as PCR fragments (Table 2)
in pGADT7 vector and used as a prey (Table 3). Plasmids
pGADT7 lacking prey and pGADT7 containing non-
specific/non-interactor proteins (simian virus 40 large-T
antigen [amino acid 87–708]) were used as negative
controls. The pGBKT7- and pGADT7-derived constructs
encoding various PAdV-3 proteins were cotransformed into
the AH 109 yeast strain (Table 3) and grown as per the
instructions of the manufacturer (BD Biosciences, Clon-
tech). The existence of an interaction between two proteins
led to the activation of the reporter genes, which allowed
growth on media lacking histidine (His) and adenine (Ade).
As seen in Fig. 1A, IVa2 and pVIII appear to interact with
each other. Similar results were observed when pVIII was
used as bait in pGBKT7 vector and IVa2 was used as a preyTable 1
List of proteins used as prey
S. No. Family Protein(s) Amino acid len
1 Intermediate IVa2 453
2 L1 pIIIa 622
3 L2 pVII 171
4 L3 pVI, pX pVI: 292
pX: 72
5 L4 Protease 204
6 L5 33K, 100K,
pVIII
33K: 225; 100
pVIII: 223in pGADT7 vector (Fig. 1B). The lack of efficient growth
on media lacking His and Ade as exhibited by other
cotransformants containing the BD or AD vector control
demonstrates the specificity of the IVa2–pVIII protein–
protein interaction in our experiments (Figs. 1A and B).
Similar protein–protein interactions were observed between
52K and IVa2 in yeast two-hybrid system (manuscript in
preparation).
GST pull-down assays
To confirm the results of the yeast two-hybrid screening
assay, we first tested the association between IVa2 and pVIII
proteins in vitro using a Glutathione sulphate transferase
(GST) pull-down assay. In this assay, we determined the
binding of labeled, in vitro-translated proteins to a purified
GST fusion protein bound to Glutathione-Sepharose beads.
Initially, IVa2 ORF (amino acids 1–453) or pVIII ORF
(amino acids 1–223) was fused individually in-frame to
GST in pGEX-5X-1 to create plasmids pGEX-IVa2 and
pGEX-pVIII, respectively. The GST alone or fusion proteins
GST-IVa2 and GST-pVIII were induced and immobilized on
Glutathione-Sepharose beads as previously described (Zhou
and Tikoo, 2001). The identities of the proteins were
analyzed by Western blot using anti-GST serum (Fig. 2A).
Next, plasmids pGBKT7-IVa2 and pGADT7-pVIII contain-
ing a T7 promoter upstream of the IVa2 and pVIII coding
regions, respectively, under the control of T7 promoter were
individually transcribed and translated in vitro in the
presence of 50 ACi of [35S] methionine using the TNT
T7-coupled reticulocyte lysate system (Promega) as des-
cribed by the manufacturer. The labeled proteins were
separated by sodium dodecyl sulphate (SDS)–polyacryla-
mide gel electrophoresis (PAGE) and visualized by auto-
radiography. As seen in Fig. 2B, the in vitro-translated
mRNAs of pVIII (lane 1) and IVa2 (lane 2) resulted in the
synthesis of 25-kDa and 55-kDa proteins, respectively,
consistent with the predicted molecular weights of each
protein. Finally, the in vitro-translated individual radio-
labeled proteins were incubated with GST fusion proteins
immobilized on Glutathione-Sepharose beads for 4–6 h at
4 8C. After extensive washing with modified EBC buffer
(Dimitrova et al., 2003), the proteins were separated on 10%gth Function/Nature of protein
MLP transactivator and role in viral assembly
Structural component of the virion that makes contact
with outer aspect of the hexon
A major protein associated with adenovirus cores
pVI: hexon-associated structural/cementing protein
pX: mu core protein
Proteinase cleavage activity during virus assembly
K: 838 33 K and 100K: non-structural. pVIII: hexon-associated
structural/cementing protein that connects the viral core
with the inner surface of the capsid
Table 2
List of primers
S. No. Gene Primer sequence
1 IVa2 MS5-F—CGC GAATTCa ATG GAG ACC AAA GTG CTA
MS3-R—CGC GGATCC TTA TGG ATG TTT GGA ACG ATA
2 pIIIa DMSIIIaF—CCG GAATTC ATG GCG GCG AGC TCT GAA GCT
DMSIIIaR—CGC GGATCC TTA CAG CCC CTT GGG GGC GAT
3 pVII DMSVIIF—CCG GAATTC ATG GCC ATC CTC GTC TCG CCC
DMSVIIR—CGC GGATCC TCA GGA CGA GGT GCG TTT GCG
4 pVI DMSVIF—CCG GAATTC ATG GAG GAC CTA AGC TTT TCC
DMSVIR—CCG CTCGAG TCA GTA ACA ACG ACG GCG CTT
5 pX DMSXF—CCG GAATTC ATG CTG ACC TAC CGG TTG CGG
DMSXR—CGC GGATCC TTA ATT GCG TTG TCT AGC ACT
6 Protease DMSProF—CCG GAATTC ATG GGC AGC ACC GAG GAC GAG
DMSProR—CGC GGATCC TTA TTG CAT ATC GAG CGC TTT
7 33K DMS33F—CCG GAATTC ATG CCG CCC CTC CGG AGG AAG
DMS33F—CGC GGATCC TTA GCT CTC AGC TGG CTG ACG
8 100K DMSCentF—CCG GAATTC ATG GAA GAC CAG CAC AGC GCA
DMSCentR—CGC GGATCC CTA CGA GCC TCG CTG GGG ACG
9 pVIII DMSVIIIF—CCG GAATTC ATG AGC AAA CAA ATC CCC ACC
DMSVIIIR—CGC GGATCC TCA GTC ATA GCC TGC TAC AGA
10 pVIII (12 kDa) DMSVIIIF—CCG GAATTC ATG AGC AAA CAA ATC CCC ACC
DMSVIII (12R)—CGC GGATCC TCA GCC CCC GGC TAA TTG CAT
11 pVIII (8 kDa) DMSVIII (8F)—CCG GAATTC ATG GGC CGC TCC TCC TTC AAC
DMSVIIIR—CGC GGATCC TCA GTC ATA GCC TGC TAC AGA
a Restriction enzyme site is shown in bold.
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Fig. 2C, GST-pVIII fusion protein interacted with in vitro-
translated IVa2 (lane 1). Similarly, GST-IVa2 interacted
with in vitro-translated pVIII (lane 2). Interestingly, pVIII
appears as a smear. In vitro-translated IVa2 or pVIII pro-
teins did not interact with GST alone, demonstrating the
specificity of the assay (lanes 3 and 4). These results
suggest that IVa2 and pVIII interactions observed in theTable 3
List of yeast strain, plasmids, and recombinant plasmids
Strain, plasmid, or construct Genotype or description
Strain
AH 109 MATa, trp1-901, leu2-3, 112, ura3-52, his3-200,
GAL2UAS-GAL2TATA-ADE2, URA3::MEL1UAS-M
Plasmids
pGBKT7 GAL4 DNA-BD vector [GAL4(1-147)]; TRP1, 2
pGADT7 GAL4 AD vector [GAL4(768-881)]; LEU2, 2 Am
Constructs
Bait vectors
BD-IVa2 pGBKT7-IVa2, PCR amplified PAdV-3 IVa2 dige
BD-pVIII pGBKT7-pVIII, PCR amplified PAdV-3 pVIII dig
Prey/library vectors
AD-pIIIa pGADT7-pIIIa, PCR amplified PAdV-3 pIIIa dige
AD-pVII pGADT7-pVII, PCR amplified PAdV-3 pVII dige
AD-pVI pGADT7-pVI, PCR amplified PAdV-3 pVI diges
AD-pX pGADT7-pX, PCR amplified PAdV-3 pX digeste
AD-Protease pGADT7-protease, PCR amplified PAdV-3 protea
vector
AD-33K pGADT7-33K, PCR amplified PAdV-3 33K dige
AD-100K pGADT7-100K, PCR amplified PAdV-3 100K dig
AD-pVIII pGADT7-pVIII, PCR amplified PAdV-3 pVIII dig
AD-’T’-antigen pGADT7-T is a control plasmid that encodes a fu
(aa 768–881)
AD-IVa2 pGADT7-IVa2, PCR amplified PAdV-3 IVa2 digyeast two-hybrid assays are real and not an artifact of the
system.
In vitro co-immunoprecipitation of proteins
To confirm and extend the results of the GST pull-down
assays, we carried out in vitro co-immunoprecipitation
studies. The IVa2 and pVIII proteins were translated ingal4D, gal80D, LYS2::GAL1UAS-GAL1TATA-HIS3,
EL1TATA-lacZ
Am, c-myc tag, Kanamycinr
, HAtag, Ampicillinr
sted with EcoRI and BamH1 and the fragment ligated in pGBKT7 vector
ested with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
sted with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
sted with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
ted with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
d with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
se digested with EcoRI and BamH1 and the fragment ligated in pGADT7
sted with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
ested with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
ested with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
sion of SV40 large T-antigen (aa 87–708) and the GAL4AD
ested with EcoRI and BamH1 and the fragment ligated in pGADT7 vector
Fig. 1. Yeast two-hybrid analysis. The yeast strain AH109 was cotransformed by the indicated combinations of plasmids encoding AD (as prey) and BD (as
bait). Cotransformants were spotted/streaked on X-a-gal-containing plates lacking Leu, Trp, His, and Ade. pGADT7 and AD-dT’ antigen (pGADT7 containing
SV40 large T-antigen) were used as negative controls. (A) IVa2 protein was used as bait. (B) pVIII protein as a bait.
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vitro translated but non-labeled IVa2 and pVIII were
incubated with in vitro-translated radiolabeled pVIII and
IVa2 proteins for 4–6 h at 4 8C before immunoprecipitation
with antibodies against the non-labeled IVa2 or pVIII
proteins. The co-immunoprecipitated pVIII and IVa2 pro-
teins were separated on 10% SDS–PAGE and the radio-
labeled proteins were visualized by autoradiography. As
shown in Fig. 3A, the 25-kDa radiolabeled pVIII co-
immunoprecipitated with unlabeled IVa2 bound by anti-Fig. 2. Binding of labeled proteins to GST-fusion proteins. (A) Immunoblot ana
(lane 1), GST-IVa2 (lane 2), or GST-pVIII (lane 3) were separated on 10%
immunoblotting using anti-GST antibody. The positions of the molecular weigh
transcription/translation of plasmids. [35S]methionine-labeled, in vitro-transcribed,
PAGE gels. The positions of the molecular weight markers (M) in kDa are shown
proteins. Purified GST alone (lanes 3 and 4), GST-pVIII (lane 1), or GST-IVa2 (lan
1) or pVIII (lane 2) proteins. Bound proteins were separated by 10% SDS–PAGE
markers (M) in kDa are shown to the left.IVa2 antibodies (lane 1). Similarly, the 55-kDa radiolabeled
IVa2 co-precipitated with pVIII using pVIII-specific anti-
serum (lane 2). Interestingly, both proteins appeared as
broad bands. The immunoprecipitation results, together with
those of in vivo yeast screening assays and GST pull-down
assays, thus confirm the newly observed interactions
between IVa2 and pVIII proteins. Furthermore, the inter-
action between IVa2 and pVIII is likely to occur post-
translationally, as the in vitro co-immunoprecipitation of
IVa2 and pVIII did not require co-translation.lysis of Glutathione-Sepharose-immobilized proteins. Purified GST alone
SDS–PAGE, transferred to nitrocellulose membrane, and analyzed by
t markers (M) in kDa are shown to the right of the panel. (B) In vitro
and translated pVIII (lane 1) and IVa2 (lane 2) were separated on 12% SDS–
to the left of the panel. (C) GST pull-down assay using in vitro-translated
e 2) proteins were incubated with in vitro-translated [35S] labeled IVa2 (lane
and detected by autoradiography. The positions of the molecular weights
Fig. 3. In vitro co-immunoprecipitations of pVIII and IVa2 proteins. (A) In vitro-transcribed/translated unlabeled IVa2 and pVIII proteins were incubated with
in vitro-translated [35S] methionine-labeled pVIII (lane 1) and IVa2 (lane 2) proteins, respectively. Proteins were immunoprecipitated with anti-IVa2 serum
(lane 1) or anti-pVIII serum (lane 2), separated by 10% SDS–PAGE. The positions of the molecular weight markers (M) in kDa are shown to the left of the
panel. (B) [35S]methionine-labeled, in vitro-transcribed, and translated Myc-tagged IVa2 (lane 3), HA-tagged pVIII (lane 2), or Myc-tagged IVa2 incubated
with HA-tagged pVIII (lane 1) were immunoprecipitated with anti-Myc (lanes 1 and 3) and anti HA (lane 2), separated on 12% SDS–PAGE. The positions of
the molecular weight markers (M) in kDa are shown to the left of the panel.
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in-frame c-Myc and HA tags, respectively, we performed in
vitro co-immunoprecipitation experiments using epitope
tag-specific antibodies. As expected, anti-Myc (Sigma)
immunoprecipitated a protein of 55 kDa from in vitro-
translated myc-IVa2 mRNA (Fig. 3B, lane 3). Similarly,
anti-HA (Sigma) immunoprecipitated a protein of 25 kDa
from in vitro-translated HA-pVIII mRNA (Fig. 3B, lane 2).
For co-immunoprecipitation, myc-IVa2 and HA-pVIII were
translated in vitro in the presence of [35S] methionine and
incubated together for 4–6 h at 4 8C. The proteins were
immunoprecipitated with anti-Myc, separated on 12% SDS–
PAGE, and visualized by autoradiography. As seen in Fig.
3B, anti-Myc immunoprecipitated both c-Myc-tagged IVa2
and HA-tagged pVIII proteins (lane 1). These results
demonstrated further that IVa2 and pVIII proteins interact
with each other. Moreover, addition of epitope tag at the 5V
end did not affect the interaction between the native
proteins.
IVa2–pVIII interaction in vivo
Next, we examined whether the interaction between
pVIII and IVa2 proteins was biologically relevant. Since
adenoviral proteins often undergo post-translational modi-
fication in cells, we analyzed IVa2 and pVIII proteins by
Western blot using protein-specific antibodies. Furthermore,
to gain a better understanding of when IVa2 and pVIII
proteins were produced during the adenovirus life cycle and
to suggest optimal time frame for their interaction, we
performed time course analysis of protein expression.
Production of both IVa2 (Fig. 4A) and pVIII (Fig. 4B)
was first seen at 9 h post-infection of VIDO-R1 cells
(transformed fetal porcine retina cells Reddy et al., 1999a,1999b) and continue to be produced up to 48 h post-
infection, at which point cytopathic effect precluded further
analysis. The time course suggests that IVa2 and pVIII are
expressed almost at similar stages of PAdV-3 life cycle and
that their interaction may be detected between 9 and 48 h
post-infection. The Western blot analysis also showed that
anti-pVIII antibodies recognize three species of proteins in
the context of a viral infection (Fig. 4B). The 25-kDa
species corresponds to the unmodified pVIII gene product
and resembles the product seen in vitro. Cleavage of late
adenoviral proteins at the conserved sequences (M,I,L)
XGX-G and (M,I,L) XGG-X by the viral protease has been
well documented in human adenoviruses (Webster et al.,
1989). Sequence analysis of the PAdV-3 pVIII gene shows
that the protease cleavage sites are there. The 12-kDa and
8-kDa protein species (called VIII) seen in Fig. 4C are
consistent with the viral protease activity at these sites. Two
additional cleavage products are predicted to be 1.8 kDa and
2.9 kDa, too small for detection under our parameters.
Similarly, since IVa2 does not form a tight band in Western
blot analysis of PAdV-3-infected lysates, it is possible that
IVa2 undergoes modifications such as phosphorylation and
or glycosylation (Singh and Tikoo, in preparation).
We proceeded to test whether IVa2 and pVIII interact
during PAdV-3 infection. To accomplish this, first we
determined whether anti-IVa2 serum could co-immunopre-
cipitate pVIII from infected cell lysates. Cleared lysates
prepared from PAdV-3-infected VIDO R1 cells at 24–36 h
post-infection (when production of both IVa2 and pVIII
proteins was high) were incubated with anti-IVa2 serum
overnight at 4 8C. The proteins were separated on 10%
SDS–PAGE, transferred to nitrocellulose membrane, and
probed with anti-pVIII serum. As seen in Fig. 5A, anti-
pVIII detected a 25-kDa protein representing pVIII (lanes 3,
Fig. 4. Western blot analysis of IVa2 and pVIII. Proteins from mock (c) or PAdV-3 infected VIDOR1 cells collected at 3 h (lane 1), 6 h (lane 2), 9 h (lane 3),
12 h (lane 4), 24 h (lane 5), and 48 h (lane 6) post-infection were separated on SDS–PAGE and transferred to nitrocellulose membranes. The separated proteins
were probed in Western blots by anti-IVa2 (Panel A, 10% SDS–PAGE) or anti-pVIII (panel B, 10–20% Tris–tricine gradient PAGE). (C) Schematic diagram of
PAdV-3 pVIII and its cleavage products. Arrows indicate the location of conserved viral protease cleavage sequences.
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IVa2 serum. No such protein was detected in infected cell
lysates immunoprecipitated with preimmune serum (lane 2)
or uninfected cell lysates immunoprecipitated with anti-
IVa2 serum (lane 1). Secondly, we co-immunoprecipitated
the IVa2–pVIII protein complexes from the [35S] methio-
nine labeled lysates of PAdV-3-infected VIDO R1 cells
using either anti-IVa2 serum or anti-pVIII serum. The
complexes were analyzed on a 10–20% Tris–tricine
gradient gel (BioRad) and visualized by autoradiography.
As expected, anti-IVa2 serum (Fig. 5B, lane 1) or anti-pVIII
serum (Fig. 5B, lane 2) immunoprecipitated both IVa2 and
pVIII proteins. These results strongly suggest that IVa2
and pVIII interact specifically during PAdV-3 infection.Fig. 5. Co-immunoprecipitation of IVa2 and pVIII in virus-infected cells. (A) Pro
VIDOR1 cells were immunoprecipitated with anti-IVa2 (lane 1, 3, 4) or preim
nitrocellulose membrane. The separated proteins were probed in Western blot by an
10 Al; lanes 1, 2, 4, 20 Al) were loaded in each well. (B) Proteins from cell
immunoprecipitated with anti-IVa2 serum (lane 1) and anti-pVIII serum (lane 2)
molecular weight markers (M) in kDa is shown to the left of the panel.Although pVIII–IVa2 interaction appears to be specific, it is
possible that the antibodies against IVa2 and pVIII cross-
react with pVIII and IVa2 proteins, respectively, and thus
co-immunoprecipitate both proteins. However, immunoblot
analysis of PAdV-3-infected VIDOR1 cells lysates with
anti-IVa2 serum (Fig. 4A) or anti-pVIII (Fig. 4B) serum
detected proteins of 55 kDa and 25 kDa, respectively.
Extensive studies on human adenovirus have suggested that
cleavage of proteins by the viral protease precedes full virus
assembly (Edvardsson et al., 1976). Because the stable
virion cannot be broken without harsh denaturing con-
ditions that are not compatible with cell culture co-
immunoprecipitation assays, we did not expect to see
interactions between IVa2 and the VIII pro-cleavage speciesteins from lysates of uninfected (lane 1) or PAdV-3 infected (lane 2, 3, 4)
mune serum (lane 2), separated on 10% SDS–PAGE, and transferred to
ti-pVIII serum. Two different volumes of the co-immunoprecipitates (lane 3,
lysates of [35S]methionine-labeled PAdV-3-infected VIDO R1 cells were
and separated on 10–20% Tris–tricine gradient PAGE. The position of the
M. Singh et al. / Virology 336 (2005) 60–6966(12 kDa and 8 kDa) in the context of a cell-culture virus
infection.
Interaction of IVa2 with pVIII cleavage products
We were interested to see whether in vitro binding
assays would show co-immunoprecipitation between IVa2
and the 12-kDa and 8-kDa VIII species. We therefore
constructed two GST-fusion constructs reflecting each of
the VIII species and repeated our GST pull-down assays.
The N-terminal 12-kDa species (amino acid 1–111) or
C-terminal 8-kDa species (amino acid 154–223) of pVIII
ORF (amino acid 1–223) was fused individually in-frame
to GST in pGEX-5X-1 to create plasmid pGEX-pVIII N
and pGEX-pVIII C, respectively. The GST alone or
fusion proteins GST-pVIII, GST-pVIII N, and GST-pVIII
C were induced and immobilized on Glutathione-Sephar-
ose beads as described earlier. First, the in vitro-translated
radiolabeled IVa2 protein was incubated with individual
GST fusion proteins immobilized on Glutathione-Sephar-
ose beads for 4–6 h at 4 8C. After washing with EBC
buffer (Dimitrova et al., 2003), the proteins were
separated on 10% SDS–PAGE and visualized by auto-
radiography. As seen in Fig. 6A, full-length, N-termini
and C-termini of pVIII bind to IVa2. Secondly, clarified
supernatants of PAdV-3-infected VIDOR1 cells lysates
were incubated with individual GST fusion proteins
immobilized on Glutathione-Sepharose beads at 4 8C
overnight. After washing three times with buffer (Prom-
ega), proteins were separated on 10% SDS–PAGE,
transferred to nitrocellulose membrane, and probed with
anti-IVa2 serum. As seen in Fig. 6B, full-length, N-
termini and C-termini of pVIII bind to IVa2. Taken
together, these results suggest that IVa2 interacts inde-
pendently with both N-terminal and C-terminal fragments
of pVIII. This finding is important because it suggests
that in vitro IVa2 can interact with the 12-kDa and 8-kDa
VIII species created by endoprotease cleavage.Fig. 6. Binding of IVa2 to different forms of GST-pVIII fusion proteins. (A) Purifie
pVIII (lane 5) proteins immobilized on Glutathione-Sepharose 4B beads were in
(lanes 1, 3, 4,5) or in vitro-translated [35S]-labeled IVa2 protein (lane 2) were se
infected (lane 2) or PAdV-3-infected (lane 1, 3, 4, 5) VIDO R1 cell lysates were in
pVIII (lane 5) proteins immobilized on Glutathione-Sepharose 4B beads. Bound p
membrane. The separated proteins were probed in Western blot using anti-IVa2 sImmunofluorescence and image analysis
To study the localization of both IVa2 and pVIII proteins
during viral infection, VIDO R1 cells infected with PAdV-3
were examined 24 h post-infection by dual label immuno-
fluorescence staining using protein-specific antibodies. As
seen in Fig. 7, both pVIII (panel A) and IVa2 (panel B) were
clearly distributed into the nuclear compartment of PAdV-3-
infected cells. Moreover, the merging of the two images
showed a yellow region of colocalization (panel C). The
merged image of both proteins further confirms our findings
that these proteins mainly localize to the nuclei of VIDOR1
cells and probably interact together to carry out some
unidentified novel activity during PAdV-3 replication.Discussion
A variety of functional activities have been ascribed to
the IVa2 protein of adenovirus including DNA packaging
(Zhang and Imperiale, 2000, 2003; Zhang et al., 2001) and
control of late transcription from the major late promoter
(Padro-Mateos and Young, 2004; Tribouley et al., 1994).
Since the assembly of mature adenovirus is a multi-step
process involving protein–protein and protein–DNA inter-
actions, the involvement of IVa2 in different steps of
adenovirus virus replication may require protein–protein
interactions. Earlier report suggests that IVa2 and 52/55K
proteins interact during HAdV-5 infection (Gustin et al.,
1996; Zhang and Imperiale, 2000). Here, we present the first
evidence that IVa2 and pVIII interact during PAdV-3
infection.
Initial analysis in yeast two-hybrid system suggested that
IVa2 may interact with pVIII protein of PAdV-3. Several
lines of evidence supported this initial observation. First,
analysis of PAdV-3-infected cells co-localized IVa2 and
pVIII in the nucleus of virus-infected cells. Second, specific
interaction between IVa2 and pVIII was confirmed usingd GST alone (lane 1), GST-pVIII N (lane 3), GST-pVIII C (lane 4), or GST-
cubated with in vitro translated [35S]-labeled IVa2 protein. Bound proteins
parated by 10% SDS–PAGE and detected by autoradiography. (B) Mock-
cubated with purified GST-pVIII N (lane 3), GST-pVIII C (lane 4), or GST-
roteins were separated on 10% SDS–PAGE and transferred to nitrocellulose
erum.
Fig. 7. Immunofluorescence. VIDO R1 cells were grown on glass chamber slides and infected with wild-type PAdV-3 at a multiplicity of infection of 5. After
24 h of infection, cells were fixed and doubly labeled with mouse anti-IVa2 and rabbit anti-pVIII antisera, followed by Cy3-conjugated anti-mouse antibodies
and FITC-conjugated anti-rabbit antibodies, respectively. The cells were examined by laser scanning confocal microscopy (Zeiss LSM 510 META). (A) Rabbit
anti-pVIII antisera (green); (B) mouse anti-IVa2 antisera (red); (C) the yellow regions are where FITC and Cye3 co-localized.
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Third, using co-immunoprecipitation and Western blot
assays, we demonstrated the interaction between IVa2 and
pVIII in virus-infected cells. These results confirm that the
interaction between IVa2 and pVIII does take place in
PAdV-3 infected cells.
The detection of an interaction between proteins IVa2
and pVIII in different assay systems, including the naturally
viral-infected cells, supports a significant role for IVa2–
pVIII binding in the viral life cycle. However, the exact
purpose for this interaction during the viral infection of
VIDOR1 cells is currently unclear. Possibly, the IVa2 and
pVIII proteins together carry out some novel activity
required for the macro-molecular viral assembly process.
The IVa2 protein is known to specifically bind HAdV-5
viral genome. It is possible that the interaction of IVa2 and
pVIII gene products is important for the molecular
recognition event between the viral DNA and the various
capsid components of which pVIII is an integral and
indispensable entity. However, mutations in pVIII gene of
HAdV-5 did not affect the ability of the virus to encapsidate
its genome into the capsids (Jones and Shenk, 1978). It is
possible that the interaction of IVa2 with pVIII is important
for virion stability during and after the biogenesis of the
viral particles in a permissive host cell. Earlier report has
suggested that the mutation in pVIII of HAdV-5 affected the
overall stability of the assembled virion particles, making
them more thermo-labile and rendering them less infective
(Liu et al., 1985). The in vitro binding of IVa2 with VIII
pro-cleavage products may also reflect on the function of
IVa2–pVIII interactions, especially with our hypothesis that
similar interactions are possible within the completely
assembled virion. Interactions between IVa2 and the VIII
cleavage products may prevent complete separation of the
VIII species and could fulfill an important role such as
maintaining a quasi-stable capsid structure sufficiently
stable to sustain the harsh extra-cellular environment but
capable of disassembly upon re-infection. Identification
of single amino acid mutants of both IVa2 and pVIIIpolypeptides that prevent their interaction and assessment of
the consequence of these mutations on virus replication and
stability should provide insights into the functional impor-
tance of this novel interaction. Since this is the first report of
an interaction between proteins IVa2 and pVIII in any
adenovirus species, it would be interesting to see whether
the function of a IVa2–pVIII partnership is conserved
among other Mastadenoviruses.Materials and methods
Cells and virus
VIDO R1 cells (HAdV-5 E1 expressing fetal porcine
retina cells) (Reddy et al., 1999a, 1999b) were grown and
maintained in Eagle’s minimum essential medium (MEM)
supplemented with 10% fetal bovine serum (FBS). The
wild-type PAdV-3 6618 strain (Clarke et al., 1967) was
propagated and titrated in VIDO R1 cells.
Antibodies
Details concerning the production and characterization of
antibodies specific to IVa2 and pVIII proteins will be
described elsewhere (Singh and Tikoo, in preparation).
Briefly, anti-IVa2 serum raised against the amino-terminal
synthetic peptide corresponding to the first 32 aa residues of
IVa2 protein recognizes a protein of 55 kDa in PAdV-3
infected cells, while anti-pVIII serum raised against the
GST-pVIII fusion protein recognizes proteins of 25 kDa, 12
kDa, and 8 kDa, respectively, in PAdV-3-infected cells.
Yeast two-hybrid system
The yeast expression vectors pGBKT7 and pGADT7
(BD Biosciences Clontech) were used to examine the
protein–protein interactions. The IVa2 and pVIII ORFs
were cloned in pGBKT7 vector and used as bait (Table 3)
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encoded by L1 to L5 region were individually cloned in
pGADT7 vector and used as prey (Table 1). Plasmid
pGADT7 vector lacking the prey and pGADT7 vector
containing non-specific/non-interactor protein: simian virus
40 large-T antigen (aa 87–708) were used as controls (Table
3). All the bait as well as prey-encoding genes were PCR
amplified using the specific primer sets (Table 2) and
plasmid pFPAV200 DNA (Reddy et al., 1999a, 1999b) as a
template. The appropriate PCR-amplified DNA fragments
were cloned at EcoRI and BamH1 restriction sites except for
the pVI gene which was ligated to EcoRI and XhoI sites in-
frame either to the GAL4 DNA binding domain (aa 1–147)
or to the activation domain (aa 768–881) of GAL4 thereby
creating the GAL4 DNA-BD or GAL4-AD vectors,
respectively (Table 3). All the constructs were verified by
restriction enzyme digestions and the gene junctions were
confirmed by DNA sequence analysis. DNA manipulations
were carried out as described by Sambrook et al. (1989).
The Saccharomyces cerevisiae strain AH109 (Match-
maker GAL4 two-hybrid system 3; BD Biosciences Clon-
tech) with HIS3 , ADE2 , and MEL1 reporter genes
downstream of a GAL4-responsive promoter element was
cotransformed with pairwise combinations of bait and prey
vectors with lithium acetate as described in the manufactu-
rer’s protocol. The cotransformats were grown for 24 h in
medium lacking leucine (Leu) and tryptophan (Trp) and then
spotted onto X-a-gal plates lacking Trp and Leu to select for
cotransformants and onto X-a-gal culture plates lacking Trp,
Leu, and His to allow selection of positive interactors. The
positive interactors from the master plate (single colony or
mixed colonies) were further tested for their ability to grow
on the plates exhibiting the highest level of stringency
(X-a-gal culture plates lacking Trp, Leu, His, and Ade).
Expression and purification of GST-fusion proteins
A 1372-bp EcoRI–BamH1 (blunt end repaired by
klenow) fragment of plasmid BD-IVa2 containing full-length
IVa2 was ligated to EcoRI–Not1 (blunt end repaired by
klenow) digested plasmid pGEX-5X-1 creating plasmid
pGEX-IVa2. Similarly, a 682-bp EcoRI–BamH1 fragment
of plasmid AD-pVIII containing full-length pVIII was
ligated to EcoRI–BamH1-digested pGEX-5X-1 creating
plasmid pGEX-pVIII. The junctions of the sequence encod-
ing IVa2-GST or pVIII-GST were sequenced to ensure that
the coding domains were in-frame. The competent E. coli
strain BL121 was transformed with plasmids pGEX-5X-1,
pGEX-IVa2, or pGEX-pVIII. The GST alone or fusion
proteins GST-IVa2 and GST-pVIII were induced and
immobilized on Glutathione-Sepharose beads as described
earlier (Zhou and Tikoo, 2001). The identities of the proteins
were analyzed by Western blot using anti-GST serum.
A 341-bp fragment [encoding N-terminal 111 amino acids
of pVIII] isolated by PCR amplification [using DMSVIIIF-
front and DMSVIII(12R) reverse primers (Table 2) andplasmid AD-pVIII as a template] was digested with EcoRI–
BamH1 and ligated to EcoRI–BamH1-digested plasmid
pGEX-5X-1 creating plasmid pGEX-pVIII N. A 223-bp
fragment [encoding amino acid 154–223] amplified by PCR
[using DMSVIII (8F) front and DMSVIIIR reverse primers
(Table 2), and plasmid AD-pVIII as a template] was digested
with EcoRI–BamH1 and ligated to EcoRI–BamH1-digested
pGEX-5X-1 creating plasmid pGEX-pVIII C. The junctions
of the sequence encoding GST-pVIII N or GST-pVIII C were
sequenced to ensure that the coding domains were in-frame.
The competent E. coli strain BL121 was transformed with
plasmids pGEX-5X-1, pGEX-pVIII N, or pGEX-pVIII C.
The GST alone or fusion proteins GST-pVIII N and GST-
pVIII C were induced and immobilized on Glutathione-
Sepharose beads as described earlier (Zhou and Tikoo,
2001). The identities of the proteins were analyzed by
Western blot using anti-GST serum (data not shown).
In vitro translation and co-immunoprecipitation of proteins
Plasmid DNA (1Ag) (pGBKT7-IVa2 or pGADT7-pVIII)
was in vitro transcribed and translated using TNT T7 quick-
coupled Transcription/Translation kit (Promega) in the
presence or absence of 50 ACi of [35S]methionine. Equal
amounts of radiolabeled and non-radiolabeled proteins were
mixed at 4 8C for 4–6 h and then subjected to immunopre-
cipitation using antibodies against non-labeled proteins.
Similarly, equal amounts (Ag) of radiolabeled and non-
radiolabeled epitope-tagged proteins synthesized using TNT
T7 quick-coupled Transcription/Translation kit were mixed
at 4 8C for 4–6 h and then subjected to immunoprecipitation
with either mouse anti-c-Myc or mouse anti-HA monoclonal
antibodies conjugated to protein A Sepharose beads. Finally,
the immunoprecipitated proteins were resolved by 10%
SDS–PAGE and analyzed by autoradiography.
Immunoprecipitation/Western blotting
Monolayers of VIDO R1 cells were infected with
multiplicity of infection of 10 of wild-type PAdV-3. At
indicated times post-infection, the infected cells were
collected and analyzed by immunoprecipitation as described
(Baxi et al., 2000) using protein-specific antisera. The co-
immunoprecipitated protein(s) or PAdV-3 infected cell
lysates were analyzed by Western blot as described (Reddy
et al., 1999a, 1999b) using protein-specific antisera.
GST pull-down assays
For in vitro binding analyses, 50 Al of GST, GST-IVa2, or
GST-pVIII proteins on Glutathione-Sepharose 4B beads
(50% slurry) was preincubated with bovine serum albumin
(final concentration, 1 mg/ml) at room temperature for 15
min and then incubated on a rotating device with 10 Al of in
vitro-synthesized radiolabeled protein in a final volume of
200 Al in EBC buffer (150 mM NaCl, 1% Triton X-100, 50
M. Singh et al. / Virology 336 (2005) 60–69 69mM Tris–HCl, pH 8.0) for 4–6 h at 4 C. The beads were
washed three times in 600 Al of EBC buffer, pelleted at
500  g for 30 s, and boiled in SDS–PAGE sample buffer.
The dissociated proteins were resolved by 10% SDS–PAGE
and visualized by autoradiography.
Confocal laser scanning microscopy
VIDO R1 cells in ProNectinF (BioSource)-coated glass
chamber slides (Lab-Tek) were infected with PAdV-3 at a
multiplicity of infection of 5. At 24 h after infection,
phosphate-buffered saline (PBS)-washed cells were fixed
with ice-cold methanol/acetone (1:1) for 15 min at 20 8C
and blocked with 5% normal goat serum in PBS for 2 h at
room temperature. Finally, the cells were incubated with
mouse anti-IVa2 (1:500 dilution) or rabbit anti-pVIII serum
(1:500) followed by incubation with Cy3-conjugated
AffiPure goat anti-mouse IgG (Jackson ImmunoResearch)
or with Fluorescein (FITC)-conjugated AffiPure goat anti-
rabbit IgG (Jackson ImmunoResearch). The cells were
washed with PBS, mounted in Permount (Fisher Scientific),
and examined for fluorescence using the confocal laser-
scanning microscope.Acknowledgments
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